title: Methotrexate treatment in cutaneous lupus erythematosus: subcutaneous application is as effective as intravenous administration.
authors.forename: A
authors.initials: A
authors.lastname: Huber
authors.forename: T
authors.initials: T
authors.lastname: Tüting
authors.forename: R
authors.initials: R
authors.lastname: Bauer
authors.forename: T
authors.initials: T
authors.lastname: Bieber
authors.forename: J
authors.initials: J
authors.lastname: Wenzel
mesh_terms: D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy*; D008727:Methotrexate / Q000008:administration & dosage*; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D008727:Methotrexate